Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-30

Clinical Trial Update: Mini-dose Esketamine-dexmedetomidine Supplemented Analgesia and Long-term Outcomes [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating mini-dose esketamine with dexmedetomidine as supplemented analgesia for scoliosis surgery has completed, with focus on long-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)
  • Esketamine (esketamine)

Snippet

Sponsor: Peking University First Hospital | Conditions: Scoliosis Correction, Postoperative Analgesia | Phase 4 | Status: COMPLETED